AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V).
From the U.S. FDA-approved label for Nimodipine. Full label: DailyMed.
AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V).
From the U.S. FDA-approved label for Nimodipine. Full label: DailyMed.
Administer only enterally (e.g., oral, nasogastric tube, or gastric tube route). Do not administer intravenously or by other parenteral routes., Give one hour before a meal or two hours after a meal., Start dosing within 96 hours of the SAH., Recommended dose is 20 mL (60 mg) every 4 hours for 21 consecutive days., Nasogastric or Gastric Tube Administration: Administer 20 mL (60 mg) every 4 hours with an oral syringe. Refill syringe with 20 mL of 0.9% saline water solution; flush remaining contents from nasogastric or gastric tube into stomach., Patients with Cirrhosis: Reduce dosage to 10 mL (30 mg) every 4 hours.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Hypotension: Monitor blood pressure., Patients with Cirrhosis: Higher risk of adverse reactions. Monitor blood pressure and pulse., CYP3A4 Strong Inhibitors: May significantly increase risk of hypotension. Concomitant use with nimodipine should generally be avoided., CYP3A4 Strong Inducers: May significantly reduce efficacy of nimodipine. Concomitant use with nimodipine should generally be avoided. 5.1 Hypotension Blood pressure should be carefully monitored during treatment with nimodipine.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The safety and efficacy of nimodipine oral solution in the treatment of patients with SAH is based on adequate and well-controlled studies of nimodipine oral capsules in patients with SAH. Nimodipine oral solution has comparable bioavailability to nimodipine oral capsules. The following clinically significant adverse reaction appears in other sections of the labeling: Hypotension.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
20 products from 17 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Nimocer 10mg Tablet | Nimodipine (10mg) | Micro Labs Ltd. | |
| Nimocer 30mg Tablet | Nimodipine (30mg) | Micro Labs Ltd. | |
| Nimocer Syrup | Nimodipine | Universal Formulation | |
| Nimodip 30mg Tablet | Nimodipine (30mg) | Usv Ltd. | |
| Vasotop 30mg Tablet | Nimodipine (30mg) | Cipla Ltd. | |
| Caldip 10mg Infusion | Nimodipine (10mg) | Alfa Igra Inc | bottle of 10 infusions |
| Nimocard Infusion | Nimodipine (10mg) | New Medicon Pharma Labs Pvt Ltd | bottle of 50 ml Infusion |
| Nimodec 10mg Infusion | Nimodipine (10mg) | United Biotech Pvt Ltd | bottle of 50 ml Infusion |
| Nimodec 30mg Tablet | Nimodipine (30mg) | United Biotech Pvt Ltd | strip of 10 tablets |
| Nimodep 30mg Tablet | Nimodipine (30mg) | Johnlee Pharmaceuticals Pvt Ltd | strip of 10 tablets |
| Nimodinol 30mg Tablet | Nimodipine (30mg) | Knoll Pharmaceuticals Ltd | strip of 10 tablets |
| Nimodip 10mg Infusion | Nimodipine (10mg) | USV Ltd | bottle of 50 ml Infusion |
| Nimodip Tablet | Nimodipine (30mg) | USV Ltd | strip of 10 tablets |
| Nimomeg 10mg Infusion | Nimodipine (10mg) | Ridhima Biocare | bottle of 50 ml Infusion |
| Nimomine 30mg Tablet | Nimodipine (30mg) | Shinto Organics (P) Limited | strip of 10 tablets |
| Nimotide 30mg Tablet | Nimodipine (30mg) | Torrent Pharmaceuticals Ltd | strip of 6 tablets |
| Nimotime 30mg Tablet | Nimodipine (30mg) | Care Formulation Labs Pvt Ltd | strip of 10 tablets |
| Nimotor 30 Tablet | Nimodipine (30mg) | Cnscure India Pvt Ltd | strip of 10 tablets |
| Nimpod 30mg Tablet | Nimodipine (30mg) | Intas Pharmaceuticals Ltd | strip of 10 tablets |
| Vasotop 30mg Infusion | Nimodipine (30mg) | Cipla Ltd | bottle of 50 ml Infusion |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store between 20°C to 25°C (68°F to 77°F); Protect from light.
Storage information from the U.S. FDA-approved label.
Nimodipine is recorded in the NepalDoc medicine catalog for: Subarachnoid haemorrhage, Stroke prevention.
For Stroke prevention: Nifedipine, Rosuvastatin, Warfarin.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
